Alternative benzoxazole assembly discovered in anaerobic bacteria provides access to privileged heterocyclic scaffold.

Horch T, Molloy EM, Bredy F, Haensch VG, Scherlach K, Dunbar KL, Franke J, Hertweck C (2022) Alternative benzoxazole assembly discovered in anaerobic bacteria provides access to privileged heterocyclic scaffold. Angew Chem Int Ed , e202205409.

Abstract

Benzoxazole scaffolds feature prominently in diverse synthetic and natural product-derived pharmaceuticals. Our understanding of their bacterial biosynthesis is, however, limited to ortho-substituted heterocycles from Actinomycetes. We report an overlooked biosynthetic pathway in anaerobic bacteria (typified in Clostridium cavendishii) that expands the benzoxazole chemical space to meta-substituted heterocycles and heralds a distribution beyond Actinobacteria. The first benzoxazoles from the anaerobic realm (closoxazole A and B) were elucidated by NMR and chemical synthesis. By genome editing in the native producer, heterologous expression in Escherichia coli, and systematic pathway dissection we show that closoxazole biosynthesis invokes an unprecedented precursor usage (3-amino-4-hydroxybenzoate) and manner of assembly. Synthetic utility was demonstrated by the precursor-directed biosynthesis of a tafamidis analogue. A bioinformatic survey reveals the pervasiveness of related gene clusters in diverse bacterial phyla.

Leibniz-HKI-Authors

Florian Bredy
Kyle Dunbar
Jakob Franke
Veit Hänsch
Christian Hertweck
Therese Horch
Evelyn Molloy
Kirstin Scherlach

Identifier

doi: 10.1002/anie.202205409

PMID: 35656913